Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FCRF6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $99,505
Award facts
- Contract value 100% obligated
- $99,504.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $99,504.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, awarded on November 3, 2025, with an ultimate completion date of November 25, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to streamline pharmaceutical supply to Department of Defense healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, establishes the company as a regional prime vendor contractor authorized to supply a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables. This delivery order for Stelara, a biologic immunosuppressant, reflects the contractor's established role in supporting the diverse pharmaceutical requirements of military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FCRF6?
SPE2DR26FCRF6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FCRF6 worth?
The government has obligated $99,505 on SPE2DR26FCRF6.
Is contract SPE2DR26FCRF6 an order under another contract?
Yes. SPE2DR26FCRF6 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRF6 competed?
The extent of competition for SPE2DR26FCRF6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award